aluates Reports

$ 0.0

Automative

Global Pneumococcal Bacteria Vaccine Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-35W5268

Global Pneumococcal Bacteria Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Pneumococcal Bacteria Vaccine Market Research Report 2025

Code: QYRE-Auto-35W5268

Report

July 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Walvax

GSK

Merck

Pfizer Inc

Sinopharm

Sanofi

Pneumococcal Bacteria Vaccine Market Size

The global market for Pneumococcal Bacteria Vaccine was valued at US$ 7782 million in the year 2024 and is projected to reach a revised size of US$ 10470 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Pneumococcal Bacteria Vaccine Market

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pneumococcal Bacteria Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Bacteria Vaccine.

The Pneumococcal Bacteria Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumococcal Bacteria Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pneumococcal Bacteria Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pneumococcal Bacteria Vaccine Market Report

Report Metric	Details
Report Name	Pneumococcal Bacteria Vaccine Market
Accounted market size in year	US$ 7782 million
Forecasted market size in 2031	US$ 10470 million
CAGR	4.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	PPSV 23 PCV 13 PCV 10
Segment by Application	Infant Children Adult
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Sanofi, Sinopharm, Pfizer, Walvax, GSK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Bacteria Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Bacteria Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pneumococcal Bacteria Vaccine Market growing?

Ans: The Pneumococcal Bacteria Vaccine Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Pneumococcal Bacteria Vaccine Market size in 2031?

Ans: The Pneumococcal Bacteria Vaccine Market size in 2031 will be US$ 10470 million.

Who are the main players in the Pneumococcal Bacteria Vaccine Market report?

Ans: The main players in the Pneumococcal Bacteria Vaccine Market are Merck, Sanofi, Sinopharm, Pfizer, Walvax, GSK

What are the Application segmentation covered in the Pneumococcal Bacteria Vaccine Market report?

Ans: The Applications covered in the Pneumococcal Bacteria Vaccine Market report are Infant, Children, Adult

What are the Type segmentation covered in the Pneumococcal Bacteria Vaccine Market report?

Ans: The Types covered in the Pneumococcal Bacteria Vaccine Market report are PPSV 23, PCV 13, PCV 10

Recommended Reports

Pneumococcal Vaccines

Other Human Vaccines

Vaccine Delivery & Packaging

1 Pneumococcal Bacteria Vaccine Market Overview

1.1 Product Definition

1.2 Pneumococcal Bacteria Vaccine by Type

1.2.1 Global Pneumococcal Bacteria Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 PPSV 23

1.2.3 PCV 13

1.2.4 PCV 10

1.3 Pneumococcal Bacteria Vaccine by Application

1.3.1 Global Pneumococcal Bacteria Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Infant

1.3.3 Children

1.3.4 Adult

1.4 Global Pneumococcal Bacteria Vaccine Market Size Estimates and Forecasts

1.4.1 Global Pneumococcal Bacteria Vaccine Revenue 2020-2031

1.4.2 Global Pneumococcal Bacteria Vaccine Sales 2020-2031

1.4.3 Global Pneumococcal Bacteria Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pneumococcal Bacteria Vaccine Market Competition by Manufacturers

2.1 Global Pneumococcal Bacteria Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pneumococcal Bacteria Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pneumococcal Bacteria Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Date of Enter into This Industry

2.8 Global Pneumococcal Bacteria Vaccine Market Competitive Situation and Trends

2.8.1 Global Pneumococcal Bacteria Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pneumococcal Bacteria Vaccine Players Market Share by Revenue

2.8.3 Global Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pneumococcal Bacteria Vaccine Market Scenario by Region

3.1 Global Pneumococcal Bacteria Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pneumococcal Bacteria Vaccine Sales by Region: 2020-2031

3.2.1 Global Pneumococcal Bacteria Vaccine Sales by Region: 2020-2025

3.2.2 Global Pneumococcal Bacteria Vaccine Sales by Region: 2026-2031

3.3 Global Pneumococcal Bacteria Vaccine Revenue by Region: 2020-2031

3.3.1 Global Pneumococcal Bacteria Vaccine Revenue by Region: 2020-2025

3.3.2 Global Pneumococcal Bacteria Vaccine Revenue by Region: 2026-2031

3.4 North America Pneumococcal Bacteria Vaccine Market Facts & Figures by Country

3.4.1 North America Pneumococcal Bacteria Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pneumococcal Bacteria Vaccine Sales by Country (2020-2031)

3.4.3 North America Pneumococcal Bacteria Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pneumococcal Bacteria Vaccine Market Facts & Figures by Country

3.5.1 Europe Pneumococcal Bacteria Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pneumococcal Bacteria Vaccine Sales by Country (2020-2031)

3.5.3 Europe Pneumococcal Bacteria Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pneumococcal Bacteria Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Pneumococcal Bacteria Vaccine Market Facts & Figures by Country

3.7.1 Latin America Pneumococcal Bacteria Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pneumococcal Bacteria Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pneumococcal Bacteria Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pneumococcal Bacteria Vaccine Sales by Type (2020-2031)

4.1.1 Global Pneumococcal Bacteria Vaccine Sales by Type (2020-2025)

4.1.2 Global Pneumococcal Bacteria Vaccine Sales by Type (2026-2031)

4.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Pneumococcal Bacteria Vaccine Revenue by Type (2020-2031)

4.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Type (2020-2025)

4.2.2 Global Pneumococcal Bacteria Vaccine Revenue by Type (2026-2031)

4.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Pneumococcal Bacteria Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pneumococcal Bacteria Vaccine Sales by Application (2020-2031)

5.1.1 Global Pneumococcal Bacteria Vaccine Sales by Application (2020-2025)

5.1.2 Global Pneumococcal Bacteria Vaccine Sales by Application (2026-2031)

5.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Pneumococcal Bacteria Vaccine Revenue by Application (2020-2031)

5.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Application (2020-2025)

5.2.2 Global Pneumococcal Bacteria Vaccine Revenue by Application (2026-2031)

5.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Pneumococcal Bacteria Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck Pneumococcal Bacteria Vaccine Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Sanofi

6.2.1 Sanofi Company Information

6.2.2 Sanofi Description and Business Overview

6.2.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sanofi Pneumococcal Bacteria Vaccine Product Portfolio

6.2.5 Sanofi Recent Developments/Updates

6.3 Sinopharm

6.3.1 Sinopharm Company Information

6.3.2 Sinopharm Description and Business Overview

6.3.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sinopharm Pneumococcal Bacteria Vaccine Product Portfolio

6.3.5 Sinopharm Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer Pneumococcal Bacteria Vaccine Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Walvax

6.5.1 Walvax Company Information

6.5.2 Walvax Description and Business Overview

6.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Walvax Pneumococcal Bacteria Vaccine Product Portfolio

6.5.5 Walvax Recent Developments/Updates

6.6 GSK

6.6.1 GSK Company Information

6.6.2 GSK Description and Business Overview

6.6.3 GSK Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GSK Pneumococcal Bacteria Vaccine Product Portfolio

6.6.5 GSK Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pneumococcal Bacteria Vaccine Industry Chain Analysis

7.2 Pneumococcal Bacteria Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pneumococcal Bacteria Vaccine Production Mode & Process Analysis

7.4 Pneumococcal Bacteria Vaccine Sales and Marketing

7.4.1 Pneumococcal Bacteria Vaccine Sales Channels

7.4.2 Pneumococcal Bacteria Vaccine Distributors

7.5 Pneumococcal Bacteria Vaccine Customer Analysis

8 Pneumococcal Bacteria Vaccine Market Dynamics

8.1 Pneumococcal Bacteria Vaccine Industry Trends

8.2 Pneumococcal Bacteria Vaccine Market Drivers

8.3 Pneumococcal Bacteria Vaccine Market Challenges

8.4 Pneumococcal Bacteria Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Walvax

GSK

Merck

Pfizer Inc

Sinopharm

Sanofi

List of Tables

Table 1. Global Pneumococcal Bacteria Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pneumococcal Bacteria Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pneumococcal Bacteria Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pneumococcal Bacteria Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Pneumococcal Bacteria Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pneumococcal Bacteria Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pneumococcal Bacteria Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pneumococcal Bacteria Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pneumococcal Bacteria Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Bacteria Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pneumococcal Bacteria Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pneumococcal Bacteria Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Pneumococcal Bacteria Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Pneumococcal Bacteria Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Pneumococcal Bacteria Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Pneumococcal Bacteria Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pneumococcal Bacteria Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America Pneumococcal Bacteria Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America Pneumococcal Bacteria Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pneumococcal Bacteria Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pneumococcal Bacteria Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pneumococcal Bacteria Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Pneumococcal Bacteria Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pneumococcal Bacteria Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pneumococcal Bacteria Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Pneumococcal Bacteria Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pneumococcal Bacteria Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global Pneumococcal Bacteria Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Pneumococcal Bacteria Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global Pneumococcal Bacteria Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global Pneumococcal Bacteria Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global Pneumococcal Bacteria Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Pneumococcal Bacteria Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global Pneumococcal Bacteria Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Merck Pneumococcal Bacteria Vaccine Product

Table 74. Merck Recent Developments/Updates

Table 75. Sanofi Company Information

Table 76. Sanofi Description and Business Overview

Table 77. Sanofi Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Sanofi Pneumococcal Bacteria Vaccine Product

Table 79. Sanofi Recent Developments/Updates

Table 80. Sinopharm Company Information

Table 81. Sinopharm Description and Business Overview

Table 82. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Sinopharm Pneumococcal Bacteria Vaccine Product

Table 84. Sinopharm Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer Pneumococcal Bacteria Vaccine Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Walvax Company Information

Table 91. Walvax Description and Business Overview

Table 92. Walvax Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Walvax Pneumococcal Bacteria Vaccine Product

Table 94. Walvax Recent Developments/Updates

Table 95. GSK Company Information

Table 96. GSK Description and Business Overview

Table 97. GSK Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. GSK Pneumococcal Bacteria Vaccine Product

Table 99. GSK Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Pneumococcal Bacteria Vaccine Distributors List

Table 103. Pneumococcal Bacteria Vaccine Customers List

Table 104. Pneumococcal Bacteria Vaccine Market Trends

Table 105. Pneumococcal Bacteria Vaccine Market Drivers

Table 106. Pneumococcal Bacteria Vaccine Market Challenges

Table 107. Pneumococcal Bacteria Vaccine Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pneumococcal Bacteria Vaccine

Figure 2. Global Pneumococcal Bacteria Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pneumococcal Bacteria Vaccine Market Share by Type: 2024 & 2031

Figure 4. PPSV 23 Product Picture

Figure 5. PCV 13 Product Picture

Figure 6. PCV 10 Product Picture

Figure 7. Global Pneumococcal Bacteria Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Pneumococcal Bacteria Vaccine Market Share by Application: 2024 & 2031

Figure 9. Infant

Figure 10. Children

Figure 11. Adult

Figure 12. Global Pneumococcal Bacteria Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Pneumococcal Bacteria Vaccine Market Size (2020-2031) & (US$ Million)

Figure 14. Global Pneumococcal Bacteria Vaccine Sales (2020-2031) & (K Units)

Figure 15. Global Pneumococcal Bacteria Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 16. Pneumococcal Bacteria Vaccine Report Years Considered

Figure 17. Pneumococcal Bacteria Vaccine Sales Share by Manufacturers in 2024

Figure 18. Global Pneumococcal Bacteria Vaccine Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Pneumococcal Bacteria Vaccine Players: Market Share by Revenue in Pneumococcal Bacteria Vaccine in 2024

Figure 20. Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Pneumococcal Bacteria Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Pneumococcal Bacteria Vaccine Sales Market Share by Country (2020-2031)

Figure 23. North America Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2020-2031)

Figure 24. United States Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Country (2020-2031)

Figure 27. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2020-2031)

Figure 28. Germany Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Pneumococcal Bacteria Vaccine Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2020-2031)

Figure 35. China Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Country (2020-2031)

Figure 45. Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Pneumococcal Bacteria Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Pneumococcal Bacteria Vaccine by Type (2020-2031)

Figure 55. Global Revenue Market Share of Pneumococcal Bacteria Vaccine by Type (2020-2031)

Figure 56. Global Pneumococcal Bacteria Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Pneumococcal Bacteria Vaccine by Application (2020-2031)

Figure 58. Global Revenue Market Share of Pneumococcal Bacteria Vaccine by Application (2020-2031)

Figure 59. Global Pneumococcal Bacteria Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 60. Pneumococcal Bacteria Vaccine Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pneumococcal Vaccination Market Research Report 2025

Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025

Pneumococcal Vaccine Polyvalent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumonia Vaccine Market Insights Forecast to 2030

Global Bacterial Vaccines for Humans Market Research Report 2024

Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Vaccine for Non infectious Meningitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Meningococcal Group B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Research Report 2024

RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumococcal Testing Market Research Report 2024

Global Pneumococcal 13 valent Conjugate Vaccine Market Research Report 2024

BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccines For Children Market Insights Forecast to 2030

Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions